eznews.inA recent study published in *The Lancet* highlights the rising consumption of ultra-processed foods (UPFs) globally, linking their intake to an increased risk of 12 health conditions, including Crohn’s disease and diabetes. This research, part of a three-paper series, reveals that UPFs now account for over 50% of total food purchases in the US and UK, with significant increases noted in Spain, China, Mexico, and Brazil. The study's lead author, Carlos A. Monteiro, emphasizes that powerful corporations promote these foods, undermining public health efforts. Additionally, experts like Dr. Mir Ali and nutritionist Monique Richard advocate for reducing UPF consumption by incorporating healthier options into diets and encouraging home-cooked meals. Richard suggests practical strategies, such as swapping sugary drinks for infused water and choosing minimally processed foods, to help individuals make healthier dietary choices amid the prevalence of UPFs. 
Published: Nov 25 2025, 1 ameznews.inA recent study published in JAMA Network Open indicates that increased physical activity in midlife and late life may significantly reduce the risk of all-cause dementia and Alzheimer's disease. As of 2020, over 55 million people worldwide were living with dementia, a number projected to rise to 78 million by 2030. The research, which analyzed data from the Framingham Heart Study involving approximately 4,300 participants, found no significant link between physical activity in early adulthood and dementia risk. Lead researcher Phillip H. Hwang emphasized that staying active later in life could be just as crucial for dementia prevention as being active in midlife. Experts like neurologist Clifford Segil and neuropsychologist Raphael Wald echoed the study's findings, highlighting the importance of maintaining physical activity throughout life to mitigate dementia risk, alongside other health benefits. The study underscores the need for ongoing research into lifestyle factors that may influence cognitive health as we age.
Published: Nov 24 2025, 11 pmeznews.inResearchers at the University of Pennsylvania have uncovered how hydralazine, a long-established blood pressure medication, could potentially combat glioblastoma, an aggressive brain tumor. Previously, the drug's mechanism of action was unknown, but the study revealed that hydralazine works by inhibiting the enzyme 2-aminoethanethiol dioxygenase (ADO), which is crucial for blood vessel relaxation and may also play a role in tumor growth. When glioblastoma cells were treated with hydralazine, they entered a state of senescence, significantly slowing their growth. While the findings are promising, experts caution that further research is necessary before hydralazine can be considered a viable treatment option. Dr. Walavan Sivakumar noted that the discovery opens a new avenue for brain cancer therapies, particularly given hydralazine’s established safety profile and low cost. However, Dr. Nicholas Klaiber raised concerns about the potential for tumor resistance and the need for continuous treatment.
Published: Nov 23 2025, 1 pmeznews.inA recent study published in *JAMA Network Open* has revealed a significant link between obstructive sleep apnea (OSA) and cerebral microbleeds, which can increase the risk of dementia and stroke. The research, involving over 1,400 participants over eight years, found that individuals with moderate to severe OSA were more than twice as likely to develop microbleeds compared to those without the condition. The study highlights the need for early diagnosis and treatment of OSA to mitigate potential brain health risks. Researchers noted that cerebral microbleeds are associated with chronic blood product buildup in the brain and are more prevalent in older adults. Despite its insights, the study's focus on a Korean population limits its generalizability, and further research is necessary to explore the mechanisms behind OSA's impact on brain health. Experts emphasize the importance of preventive measures to improve sleep quality and reduce the chances of developing serious neurological conditions.
Published: Nov 22 2025, 5 pmeznews.inRecent research highlights the significant health risks associated with the consumption of ultra-processed foods, linking them to inflammatory bowel disease (IBD), lung cancer, and diabetes. The Food Standards Agency notes that diets high in these foods can exacerbate IBD symptoms and increase the risk of Crohn's disease. A study revealed that higher intake of ultra-processed foods correlates with a 41% increased risk of lung cancer. Additionally, even small amounts of processed meats can elevate diabetes risk; for instance, consuming just one hot dog daily raises the chance of type 2 diabetes by 11%. A recent study focused on young adults found that increased consumption of ultra-processed foods is associated with a higher risk of prediabetes. Experts advocate for a Mediterranean-style diet rich in fruits, vegetables, and whole grains as a healthier alternative to mitigate these risks.
Published: Nov 22 2025, 1 ameznews.inAs Thanksgiving approaches, health experts caution that the holiday can pose various risks, including foodborne illnesses, medication interactions, and overeating. Foods commonly served may affect medications like blood thinners and antibiotics; for instance, vitamin K in turkey can influence blood clotting, while dairy can hinder antibiotic effectiveness. Additionally, alcohol and grapefruit juice may interact negatively with numerous prescriptions. To mitigate these risks, dietitian Michelle Routhenstein recommends consulting healthcare professionals about potential interactions and suggests thoughtful meal planning, such as eating smaller meals beforehand and avoiding skipping breakfast. Proper food handling is critical to prevent contamination, with guidelines for safely thawing and cooking turkey. Encouraging mindful eating and physical activity, Routhenstein emphasizes that Thanksgiving should be about enjoyment and connection, not guilt, and promotes viewing holiday meals as part of a broader, sustainable lifestyle rather than a temporary indulgence.
Published: Nov 21 2025, 10 pmeznews.inA promising new weight loss drug, eloralintide, has demonstrated significant efficacy in Phase 2 clinical trials, achieving an average weight loss of 9-20% among participants over 48 weeks. Unlike established GLP-1 medications such as Ozempic and Wegovy, which are not universally effective and may leave up to 17% of users as "non-responders," eloralintide targets the hormone amylin, regulating appetite and metabolism. The trial included 263 adults with obesity or overweight, revealing that those treated with eloralintide experienced substantial health improvements, including reductions in hypertension and sleep apnea symptoms. Experts emphasize the importance of long-term safety and sustainability of results, with plans for Phase 3 trials to further assess its effectiveness across a diverse population. The development of eloralintide could enhance treatment options for obesity, providing a vital alternative to existing therapies and potentially expanding the therapeutic toolbox for personalized weight management.
Published: Nov 20 2025, 11 pmeznews.inResearchers are exploring natural alternatives to GLP-1 medications like Ozempic, which have revolutionized weight management and type 2 diabetes treatment. A review from Heliopolis University in Cairo highlights the potential of dietary compounds such as cinnamon, ginger, and green tea to influence the gut hormone glucagon-like peptide-1 (GLP-1), which is targeted by these medications. The search for natural substitutes is driven by the high cost and accessibility issues associated with GLP-1 injections, as well as concerns over their gastrointestinal side effects. While some natural ingredients may enhance metabolism, experts caution that their effects are mild and should not replace traditional medications. Dr. Mir Ali emphasizes the importance of a balanced diet and exercise in achieving sustainable weight loss, noting that while natural compounds can support weight management, they are not a substitute for comprehensive lifestyle changes or medical treatments.
Published: Nov 20 2025, 2 pmeznews.inRecent research indicates that the DASH (Dietary Approaches to Stop Hypertension) diet may significantly reduce the risk of complications associated with type 2 diabetes, a condition affecting over 500 million people globally. The diet, originally designed to lower blood pressure, combines high potassium, magnesium, calcium, and fiber with low sodium and saturated fats, which can enhance insulin sensitivity and improve cardiovascular health. A review published in *Frontiers in Nutrition* highlights the diet's effectiveness in regulating blood glucose levels and reducing inflammation, thereby protecting vital organs like the heart and kidneys. While the DASH diet may not dramatically lower hemoglobin A1c levels, it offers broader health benefits, including improved kidney function and reduced cardiovascular risks. Experts advise that the diet is suitable for most individuals with type 2 diabetes, although those with kidney issues or on glucose-lowering medications should consult their doctors before making dietary changes.
Published: Nov 20 2025, 3 ameznews.inA recent study has identified a potential link between the Epstein-Barr virus (EBV) and lupus, an autoimmune disease affecting over 5 million people globally. Researchers at Stanford University have found that nearly all lupus patients have evidence of past EBV infections and generate heightened immune responses to the virus. The study revealed that individuals with lupus have 25 times more EBV-infected B cells in their blood compared to healthy individuals. These cells, which can become pro-inflammatory, are believed to drive the autoimmune response associated with lupus. Senior author Dr. William Robinson emphasized that targeting these EBV-infected B cells could lead to transformative treatments or even a cure for lupus. The findings also raise questions about the role of EBV in other autoimmune diseases, suggesting that effective EBV suppression might mitigate autoimmune responses in patients. Further research is needed to validate these mechanisms and explore their implications for broader autoimmune conditions.
Published: Nov 19 2025, 12 pmFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact